Ketamine IV for the prevention of depression in the elderly: new data

Published Date: 13 Mar 2023

Intravenous (IV) ketamine is effective in adults resistant to depression. The response was similar to that seen in younger patients, two new studies show.

Read Full News

Latest News

Feeding Difficulties in Kids Increase Hospital Use and Costs

The presence of feeding difficulties was directly linked to longer hospital stays and higher costs, regardless of other factors.

US Recreational, Unintentional Marijuana Use Surges

Both recreational use and unintentional exposure to marijuana in the US rose significantly from 2015 to 2021, especially in children and adolescents, new survey data show.

ED Overcrowding Linked to Near-Tenfold Rise in Deaths

The RCEM estimates 15,860 deaths were linked to long ED waits in 2025, nearly ten times the 2015 figure.

Europe Faces Growing Synthetic Opioids Risks as Drug Market Evolves, EU Agency Warns

Europe's illicit drug market is undergoing a rapid shift, with synthetic opioids emerging as a concern, although the ⁠region still experiences far fewer fatal overdoses than...

Bipolar: The Warning Signs GPs Can Miss

Bipolar takes an average of 9.5 years to diagnose from first presentation — here's what GPs can do to spot it sooner and intervene before crisis hits.

MRI Signs of Osteitis Pubis Are Common Without Groin Pain

A large population-based study finds that bone marrow oedema and symphyseal cleft signs are common incidental findings on pelvic MRI and do not correlate with self-reported pain.

Todays Updates

Belzutifan Plus Pembro Approved for Adjuvant RCC

LITESPARK-022 trial reports a 28% decrease in risk for disease recurrence or death.

Todays Updates

Belzutifan Plus Pembro Approved for Adjuvant RCC

LITESPARK-022 trial reports a 28% decrease in risk for disease recurrence or death.

Latest News

The presence of feeding difficulties was directly linked to longer hospital stays and higher costs, regardless of other factors.

Both recreational use and unintentional exposure to marijuana in the US rose significantly from 2015 to 2021, especially in children and adolescents, new survey data show.

The RCEM estimates 15,860 deaths were linked to long ED waits in 2025, nearly ten times the 2015 figure.

Europe's illicit drug market is undergoing a rapid shift, with synthetic opioids emerging as a concern, although the ⁠region still experiences far fewer fatal overdoses than...

Bipolar takes an average of 9.5 years to diagnose from first presentation — here's what GPs can do to spot it sooner and intervene before crisis hits.

A large population-based study finds that bone marrow oedema and symphyseal cleft signs are common incidental findings on pelvic MRI and do not correlate with self-reported pain.

News All Time

Adjunctive Tirofiban Gains Ground in Stroke

Three major studies suggest intravenous or intra-arterial tirofiban may improve reperfusion outcomes without excess safety risk in selected patients with acute ischemic stroke.

Nestle and Danone Face Fresh Scrutiny Over Infant Formula Recalls

Nestle and Danone are facing fresh scrutiny over the handling of infant formula contamination after reports published on Tuesday by French, Belgian and Swiss public ⁠media...

Spanish Authorities Say Homeopathy Is No Better Than Placebo

Authorities report that stronger trial methodology consistently reduces the apparent benefits linked to homeopathic products across conditions.

Declare Climate Change a Public Health Emergency, EU Experts

A European report says the WHO should urgently scale up climate and health action in the face of waning attention.

Certain Gut-Brain Symptoms Transcend Anatomic Divisions

An expanded symptom questionnaire identified 10 gastrointestinal symptom clusters in patients with disorders of gut-brain interaction.

Ebola Deaths in Eastern Congo Rise to 131, WHO Voices Deep Concern

Twenty-six more suspected Ebola deaths were recorded in 24 hours in eastern Democratic Republic of Congo, authorities said on Tuesday, and the head of the World Health...

Cosmetic-Related Eye Injuries in Kids Up Since 2020

Pediatric eye injuries related to use of cosmetics rose 5.6% from 2020 to 2024, with toddlers most commonly affected and teens showing the largest increases, a new study finds.

AI Beats Physicians AVSs for Hospital Patients

AI over docs: AI-generated after-visit summaries are better than physician-generated ones, physician graders say. Next, patients will judge.

Can Rise of Direct Primary Care Ease Hospital Admissions?

Research has shown direct care may reduce emergency department visit and hospital use, but questions remain about equity.

Hydronephrosis on USG Predicts Stones but May Not Cut CT Use

Hydronephrosis identified on point-of-care ultrasound is linked to higher risks for stone disease and early urologic intervention in suspected renal colic but not with reduced CT use or ED stays.

US Kratom Use Surges 65-Fold in 13 Years

US Kratom use increased more than 65-fold from 2010 to 2023, with a lower incidence of adverse outcomes in states that banned the substance, new research shows.

Apnimed's Sleep Apnea Pill Meets Main Goal in Late-stage Study

Privately held biotech firm Apnimed said on Monday its experimental pill for a sleep disorder met the main ⁠goal in a late-stage trial, potentially offering a convenient...

Hidradenitis Suppurativa Tied to Higher Cardiovascular Risks

Individuals with HS show higher risks for cardiovascular outcomes, including hypertension, coronary or ischemic heart disease, venous thromboembolism, and myocardial infarction, in a meta-analysis.

African Public Health Agency Announces New Ebola Outbreak in Congo, 65 Suspected Deaths

Africa's top public health agency said on Friday that there was a confirmed Ebola outbreak in Democratic Republic of Congo's Ituri province, with 65 deaths out of 246...

Rapid Susceptibility Test Falls Short in Bacteremia

Rapid antimicrobial susceptibility testing of blood cultures is not superior to standard testing in patients with gram-negative bloodstream infections, according to the FAST trial.